Anticoagulants, antiplatelets, and thrombolytics

Provides an update on various clinically relevant in vitro and in vivo models of thrombosis and haemostasis. The editor goes further to provide highlights of the novel usage of low molecular weight heparins, newer application of GPIIb/IIIa antagonists, asprin and clopidogrel, and expanded usage of polytherapeutic approaches. The book provided a contemporary look at progress achieved during the past decade In the development of newer drugs to treat thrombotic and cardiovascular diseases. This reference explains the process of establishing these newer treatments as well as reviewing all the aspects and defining the clinically relevant models for the discovery of newer generation antithrombotics. The chapters embody a manual for hematologists, pharmacologists, vascular, and cardiovascular specialists, to use in their daily practice.